Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Advanced/Metastatic Neuroendocrine Tumors
NCT01280201Phase 2Completed
- Sponsor
- Spanish Group of Neuroendocrine Tumors
- Start
- Jan 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in Neuroendocrine Neoplasm (NEN), sponsored by Spanish Group of Neuroendocrine Tumors. Started Jan 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT01280201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280201.